Caffeine alters thermoregulatory responses to exercise in the heat only in caffeine-habituated individuals: a double-blind placebo-controlled trial

被引:8
|
作者
Hunt, Lindsey A. [1 ]
Hospers, Lily [1 ]
Smallcombe, James W. [1 ]
Mavros, Yorgi [1 ,2 ]
Jay, Ollie [1 ,2 ]
机构
[1] Univ Sydney, Fac Med & Hlth, Sydney Sch Hlth Sci, Thermal Ergon Lab, Camperdown, NSW, Australia
[2] Univ Sydney, Charles Perkins Ctr, Camperdown, NSW, Australia
关键词
body temperature; heat balance; skin blood flow; sweating; thermosensitivity; SKIN BLOOD-FLOW; ADENOSINE RECEPTORS; NITRIC-OXIDE; PROLONGED EXERCISE; OXYGEN-UPTAKE; TEMPERATURE; PERFORMANCE; PHARMACOKINETICS; RELEASE; BALANCE;
D O I
10.1152/japplphysiol.00172.2021
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
To assess the impact of acute caffeine ingestion on thermoregulatory responses during steady-state exercise under moderate heat stress conditions in caffeine-habituated and nonhabituated individuals. Twenty-eight participants [14 habituated (NAB) (4 females) and 14 nonhabituated (NHAB) (6 females)] cycled at a fixed metabolic heat production (7W.kg(-1)) for 60 min on two separate occasions 1h after ingesting 1) 5 mg.kg(-1) caffeine (CAF) or 2) 5mg.kg(-1) placebo (PLA), in a double-blinded, randomized, and counterbalanced order. Environmental conditions were 30.6 +/- 0.9 degrees C, 31 +/- 1% relative humidity (RH). The end-exercise rise in esophageal temperature (Delta T-es) from baseline was greater with CAF in the HAB group (CAF =0.88 +/- 0.29 degrees C, PLA =0.62 +/- 0.34 degrees C, P < 0.001), but not in the NHAB group (CAF =1.00 +/- 0.42 degrees C, PLA =1.00 +/- 0.39 degrees C, P = 0.94). For a given change in mean body temperature, rises in % of maximum skin blood flow were attenuated with CAF on the forearm (P = 0.015) and back (P = 0.021) in the HAB group, but not in the NHAB group (P >= 0.65). Dry heat loss was similar in the HAB (CAF =31 +/- 5 Wm(-2), PLA=33 +/- 7 Wm(-2)) and NHAB groups (CAF = 31 +/- 3 W.m(-2), PLA 30 +/- 4 Wm(-2)) (P >= 0.37). There were no differences in whole body sweat losses in both groups (HAB: CAF = 0.59 +/- 0.15 kg, PLA = 0.56 +/- 0.17 kg, NHAB:CAF = 0.53 +/- 0.19 kg, PLA 0.52 +/- 0.19 kg) (P >= 0.32). As the potential for both dry and evaporative heat loss was uninhibited by caffeine, we suggest that the observed Delta T-es, differences with CAF in the HAB group were due to alterations in internal heat distribution. Our findings support the common practice of participants abstaining from caffeine before participation in thermoregulatory research studies in compensable conditions. NEW & NOTEWORTHY We provide empirical evidence that acute caffeine ingestion exerts a thermoregulatory effect during exercise in the heat in caffeine-habituated individuals but not in nonhabituated individuals. Specifically, caffeine habituation was associated with a greater rise in esophageal temperature with caffeine compared with placebo, which appears to be driven by a blunted skin blood flow response. In contrast, no thermoregulatory differences were observed with caffeine in nonhabituated individuals. Caffeine did not affect sweating responses during exercise in the heat.
引用
收藏
页码:1300 / 1310
页数:11
相关论文
共 50 条
  • [31] A double-blind, randomized, placebo-controlled trial of melatonin as an adjuvant agent for induction of labor: The MILO trial
    Quach, Diane
    Mol, Ben W.
    Springer, Jamie
    Tully, Erin
    Higgins, Chloe
    Jones, Madeleine
    Hennes, David
    Pham, Yen
    Swarnamani, Kamala
    Palmer, Kirsten
    Davies-Tuck, Miranda
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2024, 103 (12) : 2442 - 2454
  • [32] Effects of dietary nitrate supplementation on the oxygen cost of exercise and walking performance in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled crossover trial
    Shepherd, Anthony I.
    Gilchrist, Mark
    Winyard, Paul G.
    Jones, Andrew M.
    Hallmann, Ewelina
    Kazimierczak, Renata
    Rembialkowska, Ewa
    Benjamin, Nigel
    Shore, Angela C.
    Wilkerson, Daryl P.
    FREE RADICAL BIOLOGY AND MEDICINE, 2015, 86 : 200 - 208
  • [33] Amiodarone versus lidocaine and placebo for the prevention of ventricular fibrillation after aortic crossclamping: A randomized, double-blind, placebo-controlled trial
    Mauermann, William J.
    Pulido, Juan N.
    Barbara, David W.
    Abel, Martin D.
    Li, Zhuo
    Meade, Laurie A.
    Schaff, Hartzell V.
    White, Roger D.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (05) : 1229 - 1234
  • [34] Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial
    Rangaka, Molebogeng X.
    Wilkinson, Robert J.
    Boulle, Andrew
    Glynn, Judith R.
    Fielding, Katherine
    van Cutsem, Gilles
    Wilkinson, Katalin A.
    Goliath, Rene
    Mathee, Shaheed
    Goemaere, Eric
    Maartens, Gary
    LANCET, 2014, 384 (9944) : 682 - 690
  • [35] Effect of cinnamon on migraine attacks and inflammatory markers: A randomized double-blind placebo-controlled trial
    Zareie, Azadeh
    Sahebkar, Amirhossein
    Khorvash, Fariborz
    Bagherniya, Mohammad
    Hasanzadeh, Akbar
    Askari, Gholamreza
    PHYTOTHERAPY RESEARCH, 2020, 34 (11) : 2945 - 2952
  • [36] Double-blind, placebo-controlled trial of venlafaxine to treat behavioural disorders in cats: a pilot study
    Metz, Delphine
    Medam, Tiphaine
    Masson, Sylvia
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2022, 24 (06) : 539 - 549
  • [37] Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial
    van Beers, Martijn
    Mount, Sarah W.
    Houben, Katrijn
    Gosker, Harry R.
    Schuurman, Lisanne
    Franssen, Frits M. E.
    Janssen, Daisy J. A.
    Schols, Annemie M. W. J.
    ERJ OPEN RESEARCH, 2021, 7 (04)
  • [38] A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Transcranial Photobiomodulation as Treatment for Concussion
    Taylor, Alex M.
    Mannix, Rebekah
    Zafonte, Ralph D.
    Whalen, Michael J.
    Meehan, William P., III
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2024, 56 (05) : 822 - 827
  • [39] Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for migraine prophylaxis
    Silberstein, Stephen
    Goode-Sellers, Stacey
    Twomey, Colleen
    Saiers, Jane
    Ascher, John
    CEPHALALGIA, 2013, 33 (02) : 101 - 111
  • [40] Nutritional therapy for peripheral arterial disease:: a double-blind, placebo-controlled, randomized trial of HeartBar®
    Maxwell, AJ
    Anderson, BE
    Cooke, JP
    VASCULAR MEDICINE, 2000, 5 (01) : 11 - 19